For Baby Boomers, a New Kind of Joint
“Joint replacement used to be about doing the things you needed to do — literally, being able to walk. Now, younger patients are coming and saying, ‘I want to continue…
Misinformation About IPAB
David Brooks’ op-ed in the New York Times earlier this week attacking health care reform’s Independent Payment Advisory Board has set off a mini-firestorm in the liberal blogosphere. Brooks claimed…
Johnson & Johnson’s Culture of Health Pays Off
Arguably well ahead of its time, Johnson & Johnson introduced their employee wellness program “Live for Life” in 1979. For more than 30 years, Johnson & Johnson has been working…
June 23-24 OneMedForum New York
OneMedPlace Trans-Atlantic Conference on June 23rd-24th is a gathering of fast growing, emerging healthcare and life science companies in Europe and North America. Its sixth OneMedForum, and second in New…
Squandering Medicare’s Money
Medicare spends a fortune each year on procedures that have no proven benefit and should not be covered. According to Rita F. Redberg, writing in The New York Times, examples…
WH Critical of White Paper on Projected Employer-Sponsored Coverage under Reform
The WH is striking back at a consulting firm’s report which claims that almost a third of all companies will forego the provision under the ACA which requires them to offer…
Health Care Buzz Today
One in Three Employers May Drop Health Benefits by 2014. A McKinsey Quarterly report suggests that nearly a third of employers are likely to stop offering health insurance to employees…
Obesity: Global Problem, Local Differences
According to the classification of obesity developed by the Japan Society for the Study of Obesity, obesity is defined as a BMI of 25 kg/m2 or more—lower than the WHO…
Miramar Labs lands $35.8 Million Funding for Armpit Sweat Treatment
Back in February the company received FDA 501k Clearance for the device. Wow, that’s a lot of money for a laser treatment for sweat or to stop sweat I should…
Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections
Rib-X Pharmaceuticals is developing broad spectrum antibiotics with superior coverage, safety and convenience to deliver new standards of care for patients with serious infections. Rib-X Pharmaceuticals is developing broad spectrum…
